Gene · 8542
Papers3,519
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 3,519
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Potential Interplay between HDLs and Adiponectin in Promoting Endothelial Dysfunction in Obesity. | Biomedicines | 2022 | 35740366 | PubTator, text mining | PubMed |
| Impact of APOL1 kidney risk variants on glomerular transcriptomes. | Kidney Int | 2022 | 35738828 | PubTator, text mining | PubMed |
| Identification and functional characterization of the first deep intronic GLA mutation (IVS4+1326C>T) causing renal variant of Fabry disease. | Orphanet J Rare Dis | 2022 | 35725559 | PubTator, text mining | PubMed |
| Identification of Effective and Nonpromiscuous Antidiabetic Drug Molecules from Penicillium Species. | Evid Based Complement Alternat Med | 2022 | 35722152 | PubTator, text mining | PubMed |
| Genome-wide polygenic score to predict chronic kidney disease across ancestries. | Nat Med | 2022 | 35710995 | PubTator, text mining | PubMed |
| Isolated steroid-resistant nephrotic syndrome in a Chinese child carrying a de novo mutation in WT1 gene:a case report and literature review. | BMC Pediatr | 2022 | 35710404 | PubTator, text mining | PubMed |
| Higher Affinity Antibodies Bind With Lower Hydration and Flexibility in Large Scale Simulations. | Front Immunol | 2022 | 35707541 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals potential pathogenic effectors. | Comput Struct Biotechnol J | 2022 | 35685361 | PubTator, text mining | PubMed |
| [Clinical profile and survival of patients with lupus nephritis in the department of nephrology in Cameroon: a single-center study]. | Pan Afr Med J | 2022 | 35685107 | PubTator, text mining | PubMed |
| Molecular Markers of Kidney Transplantation Outcome: Current Omics Tools and Future Developments. | Int J Mol Sci | 2022 | 35682996 | PubTator, text mining | PubMed |
| Signaling pathways of chronic kidney diseases, implications for therapeutics. | Signal Transduct Target Ther | 2022 | 35680856 | PubTator, text mining | PubMed |
| Influences of age, race, and sex on extracellular vesicle characteristics. | Theranostics | 2022 | 35673574 | PubTator, text mining | PubMed |
| COVID-19 and Acute Kidney Injury. | Crit Care Clin | 2022 | 35667738 | PubTator, text mining | PubMed |
| Immune complexome analysis of serum samples from non-small-cell lung cancer patients identifies predictive biomarkers for nivolumab therapy. | Clin Chim Acta | 2022 | 35667476 | PubTator, text mining | PubMed |
| Reduced serum high-density lipoprotein cholesterol levels and aberrantly expressed cholesterol metabolism genes in colorectal cancer. | World J Clin Cases | 2022 | 35663062 | PubTator, text mining | PubMed |
| Paraventricular Nucleus V1a Receptor Knockdown Blunts Neurocardiovascular Responses to Acute Stress in Male Rats after Chronic Mild Unpredictable Stress. | Physiol Behav | 2022 | 35661787 | PubTator, text mining | PubMed |
| Design and rationale of GUARDD-US: A pragmatic, randomized trial of genetic testing for APOL1 and pharmacogenomic predictors of antihypertensive efficacy in patients with hypertension. | Contemp Clin Trials | 2022 | 35660539 | PubTator, text mining | PubMed |
| Chronic kidney disease emerging trends in children and what to do about it. | J Natl Med Assoc | 2022 | 35660045 | PubTator, text mining | PubMed |
| Noninvasive proteomic biomarkers for alcohol-related liver disease. | Nat Med | 2022 | 35654907 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8542/papers?page=47